{"id":"https://openalex.org/W2013392444","doi":"https://doi.org/10.1097/00043426-200205000-00021","title":"Interaction Between Methotrexate and Ciprofloxacin","display_name":"Interaction Between Methotrexate and Ciprofloxacin","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2013392444","doi":"https://doi.org/10.1097/00043426-200205000-00021","mag":"2013392444","pmid":"https://pubmed.ncbi.nlm.nih.gov/11972105"},"language":"en","primary_location":{"id":"doi:10.1097/00043426-200205000-00021","doi":"https://doi.org/10.1097/00043426-200205000-00021","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00043426-200205000-00021","pdf_url":null,"source":{"id":"https://openalex.org/S15952725","display_name":"Journal of Pediatric Hematology/Oncology","issn_l":"1077-4114","issn":["1077-4114","1536-3678"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pediatric Hematology/Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014678847","display_name":"Jean\u2010Hugues Dalle","orcid":"https://orcid.org/0000-0002-8406-0793","observed_orcids":["https://orcid.org/0000-0002-8406-0793"]},"institutions":[{"id":"https://openalex.org/I4210104040","display_name":"H\u00f4pital Jeanne de Flandre","ror":"https://ror.org/01e8kn913","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210104040"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Hugues Dalle","raw_affiliation_strings":["Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France. jhdalle@wanadoo.fr","(G.V.)","(J.H.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France. jhdalle@wanadoo.fr","institution_ids":["https://openalex.org/I4210104040"]},{"raw_affiliation_string":"(G.V.)","institution_ids":[]},{"raw_affiliation_string":"(J.H.D.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036667713","display_name":"Anne Auvrignon","orcid":"https://orcid.org/0000-0002-2275-5653","observed_orcids":["https://orcid.org/0000-0002-2275-5653"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4210104040","display_name":"H\u00f4pital Jeanne de Flandre","ror":"https://ror.org/01e8kn913","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210104040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Auvrignon","raw_affiliation_strings":["From the Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France (J.H.D.)","and Service d'Oncologie Pediatrique, Institut Gustave Roussy, Villejuif, France (G.V.)","(G.V.)","(J.H.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France (J.H.D.)","institution_ids":["https://openalex.org/I4210104040"]},{"raw_affiliation_string":"and Service d'Oncologie Pediatrique, Institut Gustave Roussy, Villejuif, France (G.V.)","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"(G.V.)","institution_ids":[]},{"raw_affiliation_string":"(J.H.D.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067202962","display_name":"Gilles Vassal","orcid":"https://orcid.org/0000-0003-1780-8869","observed_orcids":["https://orcid.org/0000-0003-1780-8869"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4210104040","display_name":"H\u00f4pital Jeanne de Flandre","ror":"https://ror.org/01e8kn913","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210104040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Vassal","raw_affiliation_strings":["From the Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France (J.H.D.)","and Service d'Oncologie Pediatrique, Institut Gustave Roussy, Villejuif, France (G.V.)","(G.V.)","(J.H.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France (J.H.D.)","institution_ids":["https://openalex.org/I4210104040"]},{"raw_affiliation_string":"and Service d'Oncologie Pediatrique, Institut Gustave Roussy, Villejuif, France (G.V.)","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"(G.V.)","institution_ids":[]},{"raw_affiliation_string":"(J.H.D.)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040756049","display_name":"Guy Leverger","orcid":"https://orcid.org/0000-0002-4157-0793","observed_orcids":["https://orcid.org/0000-0002-4157-0793"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4210104040","display_name":"H\u00f4pital Jeanne de Flandre","ror":"https://ror.org/01e8kn913","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210104040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Guy Leverger","raw_affiliation_strings":["From the Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France (J.H.D.)","and Service d'Oncologie Pediatrique, Institut Gustave Roussy, Villejuif, France (G.V.)","(G.V.)","(J.H.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France (J.H.D.)","institution_ids":["https://openalex.org/I4210104040"]},{"raw_affiliation_string":"and Service d'Oncologie Pediatrique, Institut Gustave Roussy, Villejuif, France (G.V.)","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"(G.V.)","institution_ids":[]},{"raw_affiliation_string":"(J.H.D.)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5014678847"],"corresponding_institution_ids":["https://openalex.org/I4210104040"],"apc_list":null,"apc_paid":null,"fwci":1.2398,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.76007888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"24","issue":"4","first_page":"321","last_page":"322"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6133000254631042,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6133000254631042,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.07840000092983246,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":1.0},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7870000004768372},{"id":"https://openalex.org/keywords/methotrexate-toxicity","display_name":"methotrexate toxicity","score":0.878000020980835},{"id":"https://openalex.org/keywords/serum-drug-monitoring","display_name":"serum drug concentration monitoring","score":0.7200000286102295},{"id":"https://openalex.org/keywords/pediatric-cancer-chemotherapy","display_name":"pediatric cancer chemotherapy","score":0.48100000619888306},{"id":"https://openalex.org/keywords/fluoroquinolones","display_name":"fluoroquinolones","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.9380816221237183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9286736249923706},{"id":"https://openalex.org/C2776769776","wikidata":"https://www.wikidata.org/wiki/Q900898","display_name":"Probenecid","level":2,"score":0.8622028231620789},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6817195415496826},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.6118080615997314},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5428069233894348},{"id":"https://openalex.org/C174802600","wikidata":"https://www.wikidata.org/wiki/Q12190","display_name":"Penicillin","level":3,"score":0.4951087534427643},{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.47554823756217957},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44838452339172363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31147414445877075},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.3079383969306946},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2848343253135681},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.05398470163345337},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002939","descriptor_name":"Ciprofloxacin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002939","descriptor_name":"Ciprofloxacin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00043426-200205000-00021","doi":"https://doi.org/10.1097/00043426-200205000-00021","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00043426-200205000-00021","pdf_url":null,"source":{"id":"https://openalex.org/S15952725","display_name":"Journal of Pediatric Hematology/Oncology","issn_l":"1077-4114","issn":["1077-4114","1536-3678"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pediatric Hematology/Oncology","raw_type":"journal-article"},{"id":"pmid:11972105","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11972105","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pediatric hematology/oncology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W59938643","https://openalex.org/W324762618","https://openalex.org/W1982846949","https://openalex.org/W1997960159","https://openalex.org/W2020944857","https://openalex.org/W2021817113","https://openalex.org/W2156596286","https://openalex.org/W2341565573","https://openalex.org/W4241373735"],"related_works":["https://openalex.org/W2047974696","https://openalex.org/W2077738534","https://openalex.org/W2326752441","https://openalex.org/W2044814768","https://openalex.org/W3148847337","https://openalex.org/W3160495454","https://openalex.org/W2763709585","https://openalex.org/W1870474497","https://openalex.org/W2055524368","https://openalex.org/W2968676498"],"abstract_inverted_index":{"High-dose":[0],"methotrexate":[1,47],"is":[2],"used":[3],"in":[4,10,48],"malignant":[5],"hemopathies":[6],"and":[7],"solid":[8],"tumors":[9],"children.":[11],"Methotrexate":[12],"serum":[13],"concentrations":[14],"must":[15],"be":[16],"monitored":[17],"because":[18],"of":[19,23,36,43,46],"the":[20,34],"possible":[21],"toxicity":[22],"drug":[24],"elimination":[25,35,45],"delay.":[26],"Several":[27],"drugs":[28],"(e.g.,":[29],"penicillin,":[30],"probenecid)":[31],"can":[32],"alter":[33],"methotrexate.":[37],"The":[38],"authors":[39],"report":[40],"two":[41],"cases":[42],"delayed":[44],"patients":[49],"receiving":[50],"ciprofloxacin,":[51],"with":[52],"severe":[53],"toxicity.":[54]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}